Detalhe da pesquisa
1.
Postoperative radiotherapy versus no postoperative radiotherapy in patients with completely resected non-small-cell lung cancer and proven mediastinal N2 involvement (Lung ART): an open-label, randomised, phase 3 trial.
Lancet Oncol
; 23(1): 104-114, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34919827
2.
Carboplatin plus etoposide versus topotecan as second-line treatment for patients with sensitive relapsed small-cell lung cancer: an open-label, multicentre, randomised, phase 3 trial.
Lancet Oncol
; 21(9): 1224-1233, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32888454
3.
Once weekly paclitaxel associated with a fixed dose of oral metronomic cyclophosphamide: a dose-finding phase 1 trial.
BMC Cancer
; 18(1): 775, 2018 Jul 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-30064401
4.
Compared characteristics of current vs. past smokers at the time of diagnosis of a first-time lung or head and neck cancer: a cross-sectional study.
BMC Cancer
; 18(1): 372, 2018 04 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29614983
5.
Association between lung cancer somatic mutations and occupational exposure in never-smokers.
Eur Respir J
; 50(4)2017 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-29074543
6.
Immune-checkpoint inhibitors associated with interstitial lung disease in cancer patients.
Eur Respir J
; 50(2)2017 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-28798088
7.
Health-related quality of life in elderly patients with advanced non-small cell lung cancer comparing carboplatin and weekly paclitaxel doublet chemotherapy with monotherapy.
Eur Respir J
; 48(3): 861-72, 2016 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-27338193
8.
BioCAST/IFCT-1002: epidemiological and molecular features of lung cancer in never-smokers.
Eur Respir J
; 45(5): 1403-14, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25657019
9.
Second-line therapy in elderly patients with advanced nonsmall cell lung cancer.
Eur Respir J
; 43(1): 240-9, 2014 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-24114964
10.
A phase II study of cisplatin with intravenous and oral vinorelbine as induction chemotherapy followed by concomitant chemoradiotherapy with oral vinorelbine and cisplatin for locally advanced non-small cell lung cancer.
BMC Cancer
; 14: 231, 2014 Mar 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-24678902
11.
Treatment of Advanced BP-NETS with Lanreotide Autogel/Depot vs Placebo: the Phase III SPINET Study.
Endocr Relat Cancer
; 2024 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38913539
12.
Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial.
Lancet Oncol
; 13(3): 239-46, 2012 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-22285168
13.
Histo-Molecular Factors of Response to Combined Chemotherapy and Immunotherapy in Non-Small Cell Lung Cancers.
Target Oncol
; 18(6): 927-939, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37921939
14.
Surgery of primary lung carcinoid tumors at metastatic stage: A national study from the French Group of Endocrine Tumors (GTE) and ENDOCAN-RENATEN network.
J Neuroendocrinol
; 35(10): e13331, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37602933
15.
A Multicenter Study to Assess a Systematic Screening of Occupational Exposures in Lung Cancer Patients.
Int J Environ Res Public Health
; 20(6)2023 03 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-36981979
16.
Carboplatin and weekly paclitaxel doublet chemotherapy compared with monotherapy in elderly patients with advanced non-small-cell lung cancer: IFCT-0501 randomised, phase 3 trial.
Lancet
; 378(9796): 1079-88, 2011 Sep 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-21831418
17.
Brigatinib for Pretreated, ALK-Positive, Advanced Non-Small-Cell Lung Cancers: Long-Term Follow-Up and Focus on Post-Brigatinib Lorlatinib Efficacy in the Multicenter, Real-World BrigALK2 Study.
Cancers (Basel)
; 14(7)2022 Mar 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-35406523
18.
Treatment strategies for thymic carcinoma in a real-life setting. Insights from the RYTHMIC network.
Eur J Cancer
; 162: 118-127, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34965496
19.
Atezolizumab versus chemotherapy in advanced or metastatic NSCLC with high blood-based tumor mutational burden: primary analysis of BFAST cohort C randomized phase 3 trial.
Nat Med
; 28(9): 1831-1839, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35995953
20.
Comprehensive Genome Profiling in Patients With Metastatic Non-Small Cell Lung Cancer: The Precision Medicine Phase II Randomized SAFIR02-Lung/IFCT 1301 Trial.
Clin Cancer Res
; 28(18): 4018-4026, 2022 09 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35802649